Effect of Zoledronic Acid in Primary Knee Osteoarthritis

Status Recruiting

Clinical Trial Summary

We try to find out the effect of zoledronic acid over pain of primary knee osteoarthritis and also functional status in a period of 6 months.

Clinical Trial Description

This will be a double blind placebo controlled randomized clinical trial at department of rheumatology, Bangabandhu Seikh Mujib Medical University (BSMMU) from January 2023 to December 2023. Total 92 primary knee OA patients will be enrolled by following the inclusion criteria of ages 50 years and above with primary knee OA informed written consent. Then randomization will be done into group A and group B following a randomization table, each consist of 46 patients. Consecutive sampling technique will be followed. Primary knee OA will be diagnosed on the basis of ACR clinical and radiological criteria. Relevant laboratory investigations will be done. Baseline pain status will be measured by Bangla version of Western Ontario and McMaster Universities Osteoarthritis index (WOMAC), visual analog scale (VAS) and numerical rating scale (NRS) and quality of life will be measure by European quality of life scale (EQ-5D-5L). Then one group will receive single infusion of 5mg zoledronic acid and another group will receive the placebo. Each patient will be allowed take NSAIDs on requirement basis with documentation and follow non pharmacological treatment of OA. At the end of 6 months, again pain and functional status will be measured by WOMAC scale ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06051344
Study type	Interventional
Source	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Contact	Nazrul islam, MD,FCPS
Phone	8801678112396
Email	islam1nazrul@gmail.com
Status	Recruiting
Phase	Phase 4
Start date	January 1, 2023
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02139345` - TC-A Registration Study	N/A
Recruiting	`NCT05002335` - Clinical and Radiological Outcomes of Medacta Shoulder System (BE)
Active, not recruiting	`NCT03357445` - AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study	N/A
Active, not recruiting	`NCT03396224` - Avenir® Cemented Hip Stem - PMCF
Completed	`NCT02062450` - Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup	N/A
Active, not recruiting	`NCT02679352` - SMR Stemless Shoulder Arthroplasty Clinical Study	N/A
Recruiting	`NCT05926622` - Clinical and Radiological Outcomes of Medacta Shoulder System FR
Recruiting	`NCT03547947` - Clinical and Radiological Outcomes of Medacta Shoulder System
Active, not recruiting	`NCT05128500` - Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI Prosthesis
Terminated	`NCT04036279` - NANOS Neck Preserving Hip Stem
Active, not recruiting	`NCT06012656` - Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
Completed	`NCT04425603` - Anthology Hip Replacement System - Orthopaedic Data Evolution Panel (ODEP) Surveillance Study